Pantoprazole Sodium For Suspension
NDC Package 27241-256-38

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Pantoprazole Sodium for suspensions is pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). This formulation utilizes a for suspension delivery system. Marketed by Ajanta Pharma Usa Inc., this product is identified by NDC 27241-256 and is authorized under FDA application ANDA217416.

Identification & Billing

NDC Package Code
27241-256-38
Package Description
30 FOR SUSPENSION in 1 CARTON
Product Code
11-Digit Billing Format
27241025638
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
30 EA
RxNorm Crosswalk
  • RxCUI: 763306 - pantoprazole sodium 40 MG Delayed Release Oral Granules
  • RxCUI: 763306 - pantoprazole 40 MG Oral Granules
  • RxCUI: 763306 - pantoprazole 40 MG (pantoprazole sodium sesquihydrate 45.1 MG) Oral Granules
  • RxCUI: 763306 - pantoprazole 40 MG Enteric Coated Oral Granules for Oral Suspension

Clinical Specifications

Proprietary Name
Pantoprazole Sodium
Non-Proprietary Name
Pantoprazole Sodium
Substance Name
Pantoprazole Sodium
Dosage Form
For Suspension - A product, usually a solid, intended for suspension prior to administration.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

Regulatory & Marketing

Labeler Name
Ajanta Pharma Usa Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA217416
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
02-09-2023
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (27241-256). Click a package code to view its specific billing and regulatory data.

1 FOR SUSPENSION in 1 PACKET

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 27241-256-38 identifies a specific commercial package of 30 for suspension in 1 carton of Pantoprazole Sodium, a human prescription drug labeled by Ajanta Pharma Usa Inc.. This for suspension is formulated for oral use and contains pantoprazole sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ajanta Pharma Usa Inc. on February 09, 2023. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).

How is this Ajanta Pharma Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 27241025638. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 30 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
27241-256-38
11-Digit CMS (5-4-2)
27241-0256-38

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.